Table 4.
Significant differences in clinical scales and GA parameters in active group vs. placebo by H&Y factor using ANOVA with repeated measures.
UPDRS III—mean (±SD) | DST R—mean (±SD) | DST L—mean (±SD) | |||||||
---|---|---|---|---|---|---|---|---|---|
Before | After | p value | Before | After | p value | Before | After | p value | |
H&Y 2 | 23.8 (10.1) | 20.9 (8.2) | 0.050 | 12.5 (2.8) | 12.2 (2.6) | 0.048 | 13.2 (2.4) | 12.9 (2.2) | 0.038 |
H&Y 3 | 43.7 (14.0) | 35 (12.8) | 16.3 (4.2) | 14.8 (3.8) | 16.6 (4.1) | 14.9 (3.8) |